QuickView for FFM;jsessionid=70CBEF6584EA2B19DBDD770CBDEDBFF7;jsessionid=5D024CEA395B00E22A7CFA4121119BDA;jsessionid=6FA1183AB57BC42352E8018C995EB4DC (gene)

1. Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt…
2. Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-…
3. Cell-Type-Specific Complement Profiling in the ABCA4-/- Mouse Model of Stargardt Disease.
4. Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.
5. Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis.

There were no clinical trials for FFM;jsessionid=70CBEF6584EA2B19DBDD770CBDEDBFF7;jsessionid=5D024CEA395B00E22A7CFA4121119BDA;jsessionid=6FA1183AB57BC42352E8018C995EB4DC